Clinical Trials Logo

Heart Failure clinical trials

View clinical trials related to Heart Failure.

Filter by:

NCT ID: NCT04505449 Completed - Clinical trials for Heart Failure With Preserved Ejection Fraction

Invasive Left Heart Catheterization Registry

Start date: December 13, 2019
Phase:
Study type: Observational

Retrospectively enrolled suspicious of heart failure with preserved ejection fraction (HFpEF) patients who underwent left heart catheterization with the measurement of left ventricular end-diastolic pressure.

NCT ID: NCT04505384 Completed - Heart Failure Clinical Trials

Acute Effects of LBBP Versus BVP for CRT

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The study was designed to compare the acute effects of left bundle branch pacing (LBBP) with biventricular pacing (BVP) in patients with left ventricular ejection fraction (LVEF) <=35% with left bundle branch block (LBBB).

NCT ID: NCT04493346 Completed - Heart Failure Clinical Trials

Shear Wave Elastography

Start date: May 21, 2018
Phase:
Study type: Observational

In individuals needing a left ventricular assist device (LVAD), right heart failure (RHF) is a serious complication post-surgery, associated with worsened outcomes including mortality. However, predictors of decompensation after LVAD are not well established. Liver dysfunction pre-LVAD has been shown to be associated with poor outcomes post-LVAD, but the interplay between liver abnormalities and RHF post-LVAD is not well characterized. Liver stiffness (LS) is a measure associated with certain types of liver abnormalities (e.g., liver fibrosis; cirrhosis). Thus, we hypothesize that elevated LS measured by SWE is associated with increased morbidity and mortality in patients undergoing LVAD implantation and yields increased need for advanced postoperative HF therapies including the use of right ventricular assist devices (RVAD) for the management of RHF.

NCT ID: NCT04485507 Completed - Heart Failure Clinical Trials

COgnitive Intervention to Restore Attention Using Nature Environment

CORE
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Heart failure is a prevalent and serious public health concern with the growing aging population. Patients with heart failure often experience attention impairment that decreases their ability to perform self-care and diminishes their health-related quality of life. In past studies, 15 - 27% of heart failure patients had attention impairment. Attention is fundamental to human activities including self-care management of heart failure. However, cognitive interventions focusing on attention are scarce in heart failure literature. This study focuses on developing a novel cognitive intervention specifically targeting improved attention and testing its efficacy on improving attention, self-care, and health-related quality of life. The investigators in this study are asking the following 3 questions: 1) does the newly developed cognitive intervention using immersive virtual reality technology (Nature-VR) improve attention compared with the control condition (Urban-VR)?; 2) does Nature-VR intervention improve HF self-care and health-related quality of life compared with Urban-VR control condition?; and 3) are selected biological factors associated with attention function in HF? The virtual reality-based cognitive intervention (Nature-VR) can be an efficacious intervention for the patients to use and enjoy without burdening already reduced attention. This study has great potential to improve attention and prevent attention impairment, thereby leading to healthier lives among heart failure patients.

NCT ID: NCT04484298 Completed - Heart Failure Clinical Trials

Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)

dyvic2
Start date: January 2, 2019
Phase: N/A
Study type: Interventional

the study aimed to evaluate the diagnostic performance of cardiac output (CO) change after the use of trinitrine in the diagnosis of heart failure patients with acute dyspnea.

NCT ID: NCT04480151 Completed - Cardiogenic Shock Clinical Trials

ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)

ECI-BLAD
Start date: January 20, 2021
Phase:
Study type: Observational

In this retrospective observational multicenter study the authors tested the hypothesis that the use of IMPELLA™ pump as bridge to bridge, by giving the opportunity of active rehabilitation, should improve patient's outcomes after the implantation of Left Ventricular Assist Device (LVAD).

NCT ID: NCT04471610 Completed - Clinical trials for Acute Decompensated Heart Failure

Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure

Start date: January 23, 2018
Phase: N/A
Study type: Interventional

The goal of this study is to explore whether the availability of serial NT-proBNP measurements together with safety parameters such as electrolytes and creatinine may influence treatment decision in patients with acute decompensated heart failure (ADHF) leading to more rapid and faster dose increase of prognostic therapies and earlier hospital discharge.

NCT ID: NCT04466969 Completed - Hyperkalemia Clinical Trials

Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study

HKRegistrypilo
Start date: July 31, 2020
Phase:
Study type: Observational

Overall study aim of this study is to analyse descriptive statistics of Patient-Reported Outcome(PROs) which will be used in the Hyperkalemia(HK) registry study in hyperkalemia patients with Chronic Kidney Disease(CKD) or Heart Failure(HF) to describe the practice patterns of hyperkalemia treatment in in clinical practice. Based on these assessments, this study will provide the information for the applicability of PRO measurements which will be used in the Hyperkalemia registry study to the study population, i.e. CKD and/or HF patients with hyperkalemia

NCT ID: NCT04466020 Completed - Cancer Clinical Trials

SELF - BREATHE for Chronic Breathlessness

Start date: June 3, 2020
Phase:
Study type: Observational

Semi-structured qualitative interviews will be conducted to understand key factors that would enable / facilitate patients with chronic breathlessness to potentially use an online breathlessness intervention (SELF-BREATHE).

NCT ID: NCT04452578 Completed - Heart Failure Clinical Trials

Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients

Start date: June 10, 2020
Phase: N/A
Study type: Interventional

To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV negative heart recipients who are currently listed.